Sulaiman Nanji

Dr. Sulaiman Nanji is an Associate Professor in the Department of Surgery at Queen's University, affiliated with the Division of General Surgery. He holds academic appointments within the School of Medicine and conducts research through the Cancer Research Institute at Queen's University. His clinical expertise focuses on hepatobiliary and pancreatic malignancies, complemented by translational and epidemiological research.

Education: MD, PhD degrees; Royal College of Physicians and Surgeons clinical investigator designation. Dual fellowship accreditation in hepatobiliary/pancreatic surgery and multi-visceral organ transplantation. Training institutions include Universities of British Columbia, Alberta, Toronto, Emory University, Kings College Hospital (London), and NASA.

Research interests span epigenetics of liver cancer, genetic profiling for patient stratification, and health services research in HPB malignancies. Clinical interests include colorectal surgery and inflammatory bowel disease. Active in surgical oncology and translational medicine.

Labs/Teams: Conducts research through Queen's Cancer Research Institute, collaborating on epigenetic profiling and clinical trial development for hepatobiliary cancers.